NASDAQ · Price History

Hemab Therapeutics Holdings, Inc. (COAG) Stock Price History & Returns

$39.06 NASDAQ: COAG Market Cap $1.83B

Price history through Nov 17, 2026 · Source: Yahoo Finance (adjusted closes) (methodology)

How Hemab Therapeutics Holdings, Inc. (COAG) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.

The share price of $39.06 sits 50% of the way up a 52-week range of $23.00 to $55.42; 29.5% below the 52-week high; above its 50-day moving average of $36.94; above its 200-day average of $37.21; a beta of 1.85 means it has historically moved more than the market.

Total return

Price change over each trailing period, not annualised.

PeriodReturn
3 months-24.4%
6 months+48.5%

Monthly closing prices

The last 7 months, newest first. 3 of 6 months closed higher than the month before. Each figure is the last close in that month.

MonthCloseChange
November 2026$39.06-5.8%
October 2026$41.45+34.4%
September 2026$30.84-32.6%
August 2026$45.73-3.8%
July 2026$47.55+29.5%
June 2026$36.73+28.9%
May 2026$28.50—

Hemab Therapeutics Holdings, Inc. (COAG) price history — frequently asked questions

How has Hemab Therapeutics Holdings, Inc. performed over the last year?

Hemab Therapeutics Holdings, Inc. (COAG) has risen 0.0% over the last twelve months, measured on price alone.

What is Hemab Therapeutics Holdings, Inc.'s five-year return?

Over five years the COAG share price has gained 0.0%, excluding dividends.

What is Hemab Therapeutics Holdings, Inc.'s 52-week range?

Over the last year Hemab Therapeutics Holdings, Inc. (COAG) has traded between $23.00 and $55.42.

Price returns of other Biotechnology stocks

VRTX 1-year +22.4%REGN 1-year +38.2%MRNA 1-year +740.3%RVMD 1-year +137.0%ROIV 1-year +92.3%INSM 1-year -36.3%UTHR 1-year +27.9%INCY 1-year +14.8%ALNY 1-year -63.6%ASND 1-year +33.4%All Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.